Boron neutron capture therapy (BNCT) translational studies in the hamster cheek pouch model of oral cancer at the new “B2” configuration of the RA-6 nuclear reactor

[1]  R. Ferreira,et al.  Antihistamines as promising drugs in cancer therapy , 2017, Life sciences.

[2]  S. Bhattacharjee,et al.  Prolonged inflammatory microenvironment is crucial for pro-neoplastic growth and genome instability: a detailed review , 2017, Inflammation Research.

[3]  T. Rosol,et al.  Animal models of head and neck squamous cell carcinoma. , 2016, Veterinary journal.

[4]  K. Ono,et al.  Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS. , 2015, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[5]  S. Thorp,et al.  Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model. , 2015, Oral diseases.

[6]  N. Tanideh,et al.  Comparison of the therapeutic effects of the dietary and topical forms of Zizyphus jujuba extract on oral mucositis induced by 5-fluorouracil: A golden hamster model , 2015, Journal of clinical and experimental dentistry.

[7]  M. Itoiz,et al.  The hamster cheek pouch model for field cancerization studies. , 2015, Periodontology 2000.

[8]  Parul Gupta,et al.  Genetically altered fields in head and neck cancer and second field tumor , 2014, South Asian Journal of Cancer.

[9]  V. Grégoire,et al.  Advances in the management of squamous cell carcinoma of the head and neck , 2014, F1000prime reports.

[10]  R. Okayasu,et al.  Dose-rate effect was observed in T98G glioma cells following BNCT. , 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[11]  Yi-Wei Chen,et al.  Fractionated BNCT for locally recurrent head and neck cancer: experience from a phase I/II clinical trial at Tsing Hua Open-Pool Reactor. , 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[12]  S. Jensen,et al.  Oral mucosal injury caused by cancer therapies: current management and new frontiers in research. , 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[13]  Ana J. Molinari,et al.  Boron neutron capture therapy for oral precancer: proof of principle in an experimental animal model. , 2013, Oral diseases.

[14]  J. Elverdín,et al.  Protection of Radiation-Induced Damage to the Hematopoietic System, Small Intestine and Salivary Glands in Rats by JNJ7777120 Compound, a Histamine H4 Ligand , 2013, PloS one.

[15]  D. Maria,et al.  Cell cycle arrest, extracellular matrix changes and intrinsic apoptosis in human melanoma cells are induced by Boron Neutron Capture Therapy. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  M. Lingen,et al.  A novel Peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosis. , 2012, International journal of radiation oncology, biology, physics.

[17]  S. Thorp,et al.  Boron neutron capture therapy (BNCT) for liver metastasis: therapeutic efficacy in an experimental model , 2012, Radiation and environmental biophysics.

[18]  V. Medina,et al.  Histamine Receptors as Potential Therapeutic Targets for Cancer Drug Development , 2011 .

[19]  J. Hopewell,et al.  The radiobiological principles of boron neutron capture therapy: a critical review. , 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[20]  J. Bowen,et al.  Animal models of mucositis: implications for therapy. , 2011, The journal of supportive oncology.

[21]  C. Perry,et al.  Spotlight on Histamine Dihydrochloride in Acute Myeloid Leukaemia , 2011, Drugs & aging.

[22]  J. Elverdín,et al.  Histamine prevents functional and morphological alterations of submandibular glands induced by ionising radiation , 2011, International journal of radiation biology.

[23]  Ana J. Molinari,et al.  “Sequential” Boron Neutron Capture Therapy (BNCT): A Novel Approach to BNCT for the Treatment of Oral Cancer in the Hamster Cheek Pouch Model , 2011, Radiation research.

[24]  Vanina A Medina,et al.  Histamine receptors and cancer pharmacology , 2010, British journal of pharmacology.

[25]  Yuk-Kwan Chen,et al.  DMBA-induced hamster buccal pouch carcinoma and VX2-induced rabbit cancer as a model for human oral carcinogenesis , 2010, Expert review of anticancer therapy.

[26]  S. Sonis.  Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. , 2009, Oral oncology.

[27]  J. Aurelius,et al.  Post‐consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin‐2 in AML , 2009, Scandinavian journal of immunology.

[28]  M. Itoiz,et al.  Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[29]  C Yapijakis,et al.  The hamster model of sequential oral oncogenesis. , 2008, Oral Oncology.

[30]  Mariel A Núñez,et al.  Mechanisms underlying the radioprotective effect of histamine on small intestine , 2007, International journal of radiation biology.

[31]  M. Itoiz,et al.  Therapeutic Success of Boron Neutron Capture Therapy (BNCT) Mediated by a Chemically Non-selective Boron Agent in an Experimental Model of Oral Cancer: A New Paradigm in BNCT Radiobiology , 2006, Radiation research.

[32]  G. Mazzini,et al.  Clinical lessons from the first applications of BNCT on unresectable liver metastases. , 2006 .

[33]  S. Elad,et al.  A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation , 2006, Bone Marrow Transplantation.

[34]  F. Castaño,et al.  Measurement of secondary mucositis to oncohematologic treatment by means of different scale , 2005 .

[35]  Y. Yura,et al.  Effectiveness of BNCT for recurrent head and neck malignancies. , 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[36]  E. Kreimann,et al.  The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. , 2001, Cancer research.

[37]  E. Kreimann,et al.  Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model. , 2001, Cancer research.

[38]  P. Wang,et al.  Histamine inhibits chemotaxis, phagocytosis, superoxide anion production, and the production of TNFalpha and IL-12 by macrophages via H2-receptors. , 2001, International immunopharmacology.

[39]  S. Agarwala,et al.  Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment , 2001, Expert opinion on biological therapy.

[40]  A. Dorner,et al.  Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. , 2000, Oral oncology.

[41]  R. Meyer,et al.  Intradermal injections of bradykinin or histamine cause a flare-like vasodilatation in monkey. Evidence from laser doppler studies , 1990, Neuroscience Letters.

[42]  Ana J. Molinari,et al.  Tumor Blood Vessel “Normalization” Improves the Therapeutic Efficacy of Boron Neutron Capture Therapy (BNCT) in Experimental Oral Cancer , 2012, Radiation research.

[43]  S. Savolainen,et al.  Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial. , 2012, International journal of radiation oncology, biology, physics.

[44]  Ana J. Molinari,et al.  Development of a model of tissue with potentially malignant disorders (PMD) in the hamster cheek pouch to explore the long-term potential therapeutic and/or toxic effects of different therapeutic modalities. , 2010, Archives of oral biology.

[45]  S. Nagini,et al.  Black tea polyphenols protect against 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. , 2006, Oncology research.

[46]  M. Itoiz,et al.  An experimental model to demonstrate the carcinogenic action of oral chronic traumatic ulcer. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[47]  P. Scalliet,et al.  Radiobiology of Brachytherapy and the Dose-Rate Effect , 2003 .

[48]  J. Coderre,et al.  The radiation biology of boron neutron capture therapy. , 1999, Radiation research.

[49]  U. Mellqvist,et al.  Histamine and cytokine therapy. , 1998, Acta oncologica.